A recent history of failed clinical trials suggests that waiting until even the early stages of onset of Alzheimer 0 s disease may be too late for effective treatment, pointing to the importance of early intervention in young people. Early intervention will require markers of Alzheimer 0 s risk that track with genotype but are capable of responding to treatment. Here, we sought to identify a functional MRI signature of combined Alzheimer 0 s risk imparted by two genetic risk factors. We used a task of executive attention during fMRI in participants genotyped for two Alzheimer 0 s risk alleles: APOE-ε4 and CLU-C. Executive attention is a sensitive indicator of the progression of Alzheimer 0 s even in the early stages of mild cognitive impairment, but has not yet been investigated as a marker of Alzheimer 0 s risk in young adults. Functional MRI revealed that APOE-ε4 and CLU-C had an additive effect on brain activity such that increased combined genetic risk was associated with decreased brain activity during executive attention, including in the medial temporal lobe, a brain area affected early in Alzheimer 0 s pathogenesis.
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Introduction
Developing the empirical groundwork for preventive interventions against Alzheimer 0 s disease (AD) is a priority because the recent history of failed clinical trials suggests that waiting until even the early stages of frank disease onset may be too late for effective treatment (Zahs & Ashe, 2010) . Identifying neurocognitive markers of genetic risk for AD in young people is an important component of this groundwork (Goldberg & Weinberger, 2004; Green, Fugelsang, Kraemer, & Dunbar, 2008; Meyer-Lindenberg & Weinberger, 2006; Tan, Callicott, & Weinberger, 2008) . Genetic association studies of AD have repeatedly confirmed that the ε4 allele of the apolipoprotein E (APOE) gene is by far the strongest common genetic risk factor for late onset AD (e.g., Bertram, McQueen, Mullin, Blacker, & Tanzi, 2007; Harold et al., 2009; Lambert et al., 2009) . Inheritance of one copy of APOE-ε4 markedly increases the risk of AD and decreases the average age of onset (Farrer et al., 1997) . The mechanism by which APOE affects AD risk is still unclear, although mouse studies show that in normal brain, APOE-ε4 is associated with alterations in synaptic components (Dumanis, DiBattista, Miessau, Moussa, & Rebeck, 2013; Dumanis et al., 2009 ) and activity (Hunter et al., 2012) . These effects may lead to earlier amyloid deposition observed in mouse models of AD (Kim, Basak, & Holtzman, 2009) . Studies in humans suggest that, prior to clinical symptoms, APOE genotype affects medial temporal lobe (MTL) activity (Bookheimer & Burggren, 2009; Bookheimer et al., 2000) and distributed network connectivity (Pena-Gomez et al., 2012) , and that APOE-ε4 increases the risk of converting from mild cognitive impairment (MCI) to AD (Fei & Jianhua, 2012) . These data suggest that APOE-ε4 is associated with an increased susceptibility of the hippocampus and surrounding medial temporal regions to damage that occurs early in the development of AD (Liu, Kanekiyo, Xu, & Bu, 2013) .
While alleles of APOE have the strongest known effects on genetic risk for AD, genome-wide association studies have identified polymorphisms in other genes that have small but significant effects on the risk of AD (Harold, et al., 2009; Lambert et al., 2009) . Together, these genes identify several potential pathways that could affect the risk of AD, including neuroinflammation, cholesterol homeostasis, and endocytic regulation (Bertram et al., 2007) . Individual genes may affect common pathways to AD pathogenesis, or entirely independent pathways. One of these genetic risk factors is CLU, the gene for clusterin (or apolipoprotein J). Extant evidence indicates that the CLU-C polymorphism is associated with a slightly higher risk of Alzheimer 0 s disease. Large-scale meta analyses have replicated that the CLU-C allele is associated with 
